Janet K. Kim

Represented global financial services corporation in government enforcement proceedings concerning economic sanctions and corruption-related matters.

Represented global healthcare services corporation in internal investigations on corruption-related matters.

Represented global engineering, procurement and construction company on economic sanctions, export control and anti-corruption matters in negotiating and establishing a joint venture with a state-owned corporation.

Advised global financial services corporations, payment solutions providers and online service providers on compliance matters related to the evolving US economic sanctions against Iran, Cuba, Crimea and Myanmar, as well as the sectoral sanctions imposed against Russian entities.

Advised issuers on anti-corruption issues in majority- and minority-controlled joint venture transactions in Asia. Conducted due diligence, negotiated compliance-related deal terms that were tailored to the risks presented, and developed risk mitigation strategies.

Advised on M&A anti-corruption, export control, trade sanctions and anti-boycott due diligence reviews of target companies in Europe, Latin America, Asia, in collaboration with the Firm's M&A attorneys in multiple jurisdictions. Counseled on corrective measures, privilege issues during the pre-closing period, post-signing/pre-closing safeguards and post-closing compliance integration issues.

Acted as global anti-corruption compliance counsel for companies under investigation by multiple governments, advising on global compliance framework issues and remediation. Worked hand-in-hand with legal, compliance, finance and internal audit departments of these companies to ensure effective implementation within senior management and global business units. Coordinated global teams comprised of the Firm's compliance attorneys in multiple jurisdictions and also managed collateral legal issues (data privacy, works council consultations, blocking laws).

Conducted internal investigations on anti-corruption, export control and trade sanctions matters for medical device, pharmaceutical, biotechnology, oil and gas, information technology, industrial equipment and financial services companies.